0001609351-16-000051.txt : 20160602
0001609351-16-000051.hdr.sgml : 20160602
20160602161221
ACCESSION NUMBER: 0001609351-16-000051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160531
FILED AS OF DATE: 20160602
DATE AS OF CHANGE: 20160602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spark Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609351
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462654405
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 888-772-7560
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marrazzo Jeffrey D
CENTRAL INDEX KEY: 0001631262
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36819
FILM NUMBER: 161692602
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
4
1
wf-form4_146489832758981.xml
FORM 4
X0306
4
2016-05-31
0
0001609351
Spark Therapeutics, Inc.
ONCE
0001631262
Marrazzo Jeffrey D
C/O SPARK THERAPEUTICS, INC.
3737 MARKET STREET, SUITE 1300
PHILADELPHIA
PA
19104
1
1
0
0
Chief Executive Officer
Common Stock
2016-05-31
4
M
0
600
3.45
A
230600
D
Common Stock
2016-05-31
4
S
0
600
60
D
230000
D
Stock Option (right to buy)
3.45
2016-05-31
4
M
0
600
0
D
2024-07-01
Common Stock
600.0
411471
D
The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2015.
This option was granted on July 2, 2014 and vests over four years, with 25% of the shares underlying the option vesting on May 24, 2015, and the remainder vesting quarterly thereafter.
/s/ Joseph W. La Barge, attorney-in-fact for Jeffrey D. Marrazzo
2016-06-01